Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
885
datasets available to search
ShareScore release 0.9.0
Dataset results
885 results for “cyclophosphamide”
Low-dose VS High-dose IV Cyclophosphamide for Proliferative LN in Children
ClinicalTrials.gov study NCT01861561. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Neoadjuvant Treatment Pegylated Liposomal Doxorubicin Plus Cyclophosphamide Sequential Docetaxel Plus Trastuzumab and Pertuzumab Versus Docetaxel Plus Carboplatin Combined With Trastuzumab and Pertuzu
ClinicalTrials.gov study NCT05159193. IPD Sharing: NO. Countries: 1. Publications: 0.
A Dose Escalation and Expansion Study of TRX518 in Combination With Cyclophosphamide Plus Avelumab in Advanced Solid Tumors
ClinicalTrials.gov study NCT03861403. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Veliparib, Cyclophosphamide, and Doxorubicin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT00740805. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Cyclophosphamide W/or W/Out Rituximab and Peripheral Stem Cell Transplantation in Patients With Recurrent Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00028665. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase II Investigation of Pembrolizumab in Combination With Bevacizumab and Oral Cyclophosphamide in Patients With High Grade Ovarian Cancer and Surgically Documented Minimal Residual Disease After Fr
ClinicalTrials.gov study NCT06083844. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Haploidentical Stem Cell Transplantation Using Post-Transplant Cyclophosphamide
ClinicalTrials.gov study NCT03088709. IPD Sharing: NO. Countries: 1. Publications: 0.
Etoposide, Prednisone, Vincristine, Cyclophosphamide, and Doxorubicin (DA-EPOCH) With or Without Rituximab Plus Recombinant Erwinia Asparaginase (JZP458) for the Treatment of Newly Diagnosed Ph Negati
ClinicalTrials.gov study NCT06738368. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of Zilovertamab Vedotin (MK-2140) in Combination With Cyclophosphamide, Doxorubicin, and Prednisone Plus Rituximab or Rituximab Biosimilar (Truxima) (R-CHP) in Participants With Diffuse Large
ClinicalTrials.gov study NCT05406401. IPD Sharing: YES. Countries: 7. Publications: 0.
Cyclophosphamide, Fludarabine and Antithymocyte Globulin Conditioning in Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT01255319. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Donor Natural Killer Cells, Cyclophosphamide, and Etoposide in Treating Children and Young Adults With Relapsed or Refractory Solid Tumors
ClinicalTrials.gov study NCT03420963. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy Response Duration and Toxicity of Rituximab, Fludarabine, and Cyclophosphamide (RFC) as 1st Line Treatment and Rituximab (R) in Maintenance Treatment in Follicular Non Hodgkin (FNH) Lymphoma
ClinicalTrials.gov study NCT01124526. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of High Dose Cyclophosphamide in Patients With Severe Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria
ClinicalTrials.gov study NCT00004464. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Comparison Study of Dendritic Cell Vaccine With and Without Cyclophosphamide to Treat Stage IV Melanoma Patients
ClinicalTrials.gov study NCT00722098. IPD Sharing: Not stated. Countries: 1. Publications: 0.
N2007-02:Bevacizumab,Cyclophosphamide,& Zoledronic Acid in Patients W/ Recurrent or Refractory High-Risk Neuroblastoma
ClinicalTrials.gov study NCT00885326. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Phase I Study of Sorafenib Dosed Continuously With Cyclophosphamide and Doxorubicin
ClinicalTrials.gov study NCT00562913. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Evaluate the Safety and Efficacy of SCTC21C in Combination With Bortezomib, Cyclophosphamide, and Dexamethasone in Patients With Newly Diagnosed Systemic Light-Chain Amyloidosis (NDSLCA)
ClinicalTrials.gov study NCT07388602. IPD Sharing: Not stated. Countries: 1. Publications: 0.
The Safety and Efficacy of Pomalidomide in Combination With Cyclophosphamide and Dexamethasone (PCD) in the Transplant-ineligible Patients With Relapsed and/or Refractory Multiple Myeloma (MM)
ClinicalTrials.gov study NCT03242460. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Extended Follow-up of Treatment of Prednisone Plus Cyclophosphamide in Patients With Advanced-stage IgA Nephropathy
ClinicalTrials.gov study NCT03218852. IPD Sharing: NO. Countries: 1. Publications: 0.
Reduced Post-transplant Cyclophosphamide Dose in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplantation for Hematological Malignancies
ClinicalTrials.gov study NCT07193420. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.